Calendar Purple Biotech Ltd Nasdaq

Equities

PPBT

US74638P1093

Market Closed - Nasdaq 04:30:00 2024-05-08 pm EDT 5-day change 1st Jan Change
0.5497 USD +7.78% Intraday chart for Purple Biotech Ltd +5.09% -29.53%

Chart calendar Purple Biotech Ltd

3de18020da0280.LWP__JvgxhWI9OErEsrbKGP8taKzKnJKBUb2lJAdkQk.XFqVtq2N9VHsgo8ffYPsSjCy4Nf5eEQVdQ_brc8uyWt_ALSfxI6OUN2-rA~7c4562236f1842d74cc59a3e676d6913

Upcoming events on Purple Biotech Ltd

2024-06-01 02:30 pm American Society of Clinical Oncology Annual Meeting - Abstract Number: LBA4143
2024-07-31 Q2 2024 Earnings Release (Projected)
2024-11-04 Q3 2024 Earnings Release (Projected)
2025-02-04 Q4 2024 Earnings Release (Projected)

Past events on Purple Biotech Ltd

Today Q1 2024 Earnings Release (Projected)
2024-04-09 12:00 pm American Association for Cancer Research Meeting - Abstract Number 5181
2024-04-08 12:00 pm American Association for Cancer Research Meeting - Abstract Number 1939
2024-03-05 07:55 am Q4 2023 Earnings Release
2023-11-21 06:50 am Q3 2023 Earnings Release
2023-09-28 04:40 pm American Association for Cancer Research Special Conference
2023-08-22 09:29 am Q2 2023 Earnings Release
2023-05-16 04:00 pm Q1 2023 Earnings Release
2023-04-20 02:00 pm Canaccord Genuity Horizons in Oncology Virtual Conference - Panel
2021-06-04 08:30 am Jefferies Healthcare Conference
2021-06-03 American Society of Clinical Oncology Conference
2021-04-10 01:30 am American Association for Cancer Research Conference
2021-03-02 07:00 am FY 2020 Earnings Release
2021-01-20 10:30 am B. Riley Oncology Investor Conference
2021-01-05 LifeSci Advisors Corporate Access Event
2020-11-16 Jefferies Healthcare Conference
2020-11-12 09:00 am H.C. Wainwright Israel Conference
2020-08-11 07:15 am Interim 2020 Earnings Release
2020-06-21 American Association for Cancer Research Virtual Meeting
2020-05-29 08:00 am American Society of Clinical Oncology Virtual Annual Meeting - Abstract No 3094

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
0,00


1,00
4,70
-78.72%
0,00


0,00
0,00
-
0,00
0,00
-

0,00

EBITDA
Released
Forecast
Spread
0,00


0,00
0,00
-
0,00


0,00
0,00
-
0,00
0,00
-

0,00

EBIT
Million USD
Released
Forecast
Spread
0,00


-12,6
-5,81
-117.15%
0,00


-22,6
-21,7
-4.16%
-22,3
-21,2
-5.05%

-18,0

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
0,00


0,00
0,00
-
-17,8


0,00
0,00
-
0,00
-20,0
-

-13,0

Net income
Million USD
Released
Forecast
Spread
-5,85


-28,0
0,00
-
-18,4


0,00
0,00
-
0,00
-20,0
-

-13,0

EPS
USD
Released
Forecast
Spread
-0,30


0,00
0,00
-
0,00


0,00
0,00
-
0,00
0,00
-

0,00

Announcement Date11/02/2002/03/2109/02/2208/02/2305/03/24-

Quarterly results

Fiscal PeriodDecember 2022 S1 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD
Released
Forecast
Spread



0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00


0,00


0,00


0,00

EBIT
Million USD
Released
Forecast
Spread



-5,08
-4,00
-27.03%
-6,60
-5,70
-15.81%
-5,12
-6,90
25.77%
-5,14
-5,00
-2.7%
-5,75
-4,70
-22.28%
-6,27
-5,20
-20.52%

-5,20


-4,70


-4,30


-3,90

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread



















-5,00













Net income
Million USD
Released
Forecast
Spread
-10,8


















-5,00













EPS
USD
Released
Forecast
Spread
-0,06
































Announcement Date04/08/2208/11/2208/02/2316/05/2322/08/2321/11/2305/03/24----

Net sales - Quarter - Rate of surprise

Net sales - Annual - Rate of surprise

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW